A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...

The GSK share price has tumbled recently on a number of factors, but I think its fundamentals look strong, leaving the stock undervalued right now. When investing, your capital is at risk.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

KYIV - Ukraine on Nov 19 marked 1,000 days since Russia’s full-scale invasion, with weary troops battling on numerous fronts, Kyiv besieged by frequent drone and missile strikes, and officials ...

"This approval reflects our ambition to protect people at increased risk from the severe consequences of RSV infection," said GSK's chief scientific officer Tony Wood. "Adults aged 50-59 with ...

The small amount of land he has managed to seized has come at a great cost to his army and to his country’s bank account. Of course, Kyiv is nowhere near besting Moscow in this war of attrition ...

If you’re a PC gamer, you know how expensive it can be. In addition to purchasing your favorite triple-A titles, you also need a powerful machine to run them on. When it comes to gaming laptops ...